World Library  
Flag as Inappropriate
Email this Article

CCMP Capital

CCMP Capital
Limited Partnership
Industry Private Equity
Founded 1984 (2006 Spinout from JPMorgan Chase)
Headquarters 245 Park Avenue
New York City, New York, United States
Key people
Greg Brenneman, CEO
Stephen Murray, President and Chief Executive Officer
Products Leveraged buyout, Growth capital, Private equity funds
Total assets $12 billion
Website .com.ccmpcapitalwww

CCMP Capital is a leveraged buyout and growth capital transactions since inception. In 2007, CCMP was ranked #17 among World's largest private equity funds.[1]

CCMP has over 50 employees with offices in New York, London, Hong Kong and Tokyo. In 2008, CCMP hired Greg Brenneman as chairman.[2]


  • History 1
    • Panorama Capital 1.1
    • Unitas Capital 1.2
    • Linzor Capital 1.3
  • Investments 2
  • See also 3
  • References 4
  • External links 5


CCMP has been known by several names over the past two decades, originally founded as Chemical Venture Partners in 1984, to serve as the private equity and venture capital arm of Chemical Bank.

Following J.P. Morgan & Co.

Chase Capital Partners Logo (1996-2000)
JPMorgan Partners Logo (2000-2006)

In 2004,

  • CCMP Capital (official website)
  • Private Sector; When the Limelight Turns Harsh (July 29, 2001)

External links

  1. ^ Private Equity International's list of the 50 largest private equity firms
  2. ^ "Eddie Bauer Files for Bankruptcy" by Stephanie Rosenbloom and Michael J. de la Merced, The New York Times, June 17, 2009 (6/18/09, p. B3, NY ed.). Retrieved 6/18/09.
  3. ^ One Equity Partners manages approximately $8 billion in private equity commitments for JPMorgan Chase
  4. ^ Bear Stearns private equity units face uncertain future (Private Equity Online, 2008)
  5. ^ JPMorgan Chase Announces Changes to Private Equity Business.
  6. ^ Goldman and Canada in $925m JP Morgan deal (Dow Jones Financial News, 2006).
  7. ^
  8. ^ Panorama Capital closes first independent fund on $240m (PrivateEquityOnline)
  9. ^ Panorama Capital Closes Its Inaugural Fund (EuroInvestor)
  10. ^ CCMP Capital Asia closes third fund on $1.2bn, plans to change name to Unitas Capital
  11. ^ Linzor Capital Partners (company website). Accessed November 28, 2012
  12. ^ Linzor Launches Second Fund. Mergers & Acquisitions, August 9, 2010
  13. ^ An Interview with Tim Purcell, Linzor Capital Partners. Latin American Private Equity & Venture Capital Association, November 6, 2009
  14. ^ a b c d
  15. ^ Aramark Will Be Acquired (New York Times, August 9, 2006)
  16. ^ Berry Plastics to Be Sold Again (New York Times, June 29, 2006),
  17. ^ Blackstone Leads Group Buying Food Company (New York Times, February 13, 2007)
  18. ^ Turnaround Expert Is Named Quiznos Chief (New York Times, January 9, 2007)
  19. ^ Hospital Chain Accepts Buyout By a Partnership for $4.7 Billion (New York Times, February 6, 2007)
  20. ^


See also

CCMP manages both the JP Morgan Partners Global Fund and CCMP Capital Investors II. Among CCMP's investments are the following portfolio companies:


Among the other notable spinouts from CCMP's predecessor, JPMorgan Partners was Linzor Capital Partners. Linzor, which focuses on private equity investments in Latin America, was founded in 2006 by Tim Purcell, Alfredo Irigoin and Carlos Ingham.[11] In 2000, Tim Purcell and Alfredo Irigoin had founded J.P. Morgan Partners Latin America a leading investor in private equity transactions in Latin America. Prior to the merger of J.P. Morgan and Chase in 2000, Purcell had been responsible for J.P. Morgan Capital’s Latin American private equity portfolio from the mid-1990s.[12][13]

Linzor Capital

In December 2008, CCMP Capital Asia, which had operated increasingly autonomously of the US and European teams, completed a formal separation from CCMP Capital, changing its name to Unitas Capital. CCMP Capital Asia, which operated separate private equity investment funds had co-invested in several transactions alongside the global funds.[10]

Unitas Capital

Based in Menlo Park, California, Panorama continues to focus on early and expansion-stage opportunities in both the information technology and life sciences sectors. Panorama began raising its first independent fund in October 2005, with a target size of $500 million. After more than a year of fundraising, Panorama closed on approximately $240 million of investor commitments.[8][9]

Prior to its spin out from leveraged buyout, growth capital and venture capital transactions. Following the spinout, the investment professionals focused on venture capital transactions separated from the CCMP Capital team to form a new firm, Panorama Capital.

Panorama Capital

In February 2014, CCMP sold the pharmaceutical contract research organisation Medpace to Cinven for around $900 million.[7]

In 2007, CCMP completed fundraising for its most recent fund, closing on $3.4 billion in commitments from institutional investors for CCMP Capital Investors II. CCMP Capital Investors II, represented the first fund raised by the CCMP team subsequent to its split from JPMorgan Chase and came in slightly below the original $3.5 billion target that CCMP set for the fundraising.

The spinout of CCMP came at the same time as the spinouts of private equity groups from other leading investment banks including: Metalmark Capital), Citigroup (Court Square Capital Partners), Deutsche Bank (MidOcean Partners) and Credit Suisse First Boston (Avista Capital Partners, Diamond Castle Holdings).

JP Morgan Partners announced the spinout in March 2005 and completed the separation from JPMorgan Chase effective July 31, 2006.[5] The new firm adopted the CCMP acronym in reference to its predecessor entities (i.e., Chemical and Chase and JP Morgan Partners). In April 2006, secondary investors.[6]


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.